Results 31 to 40 of about 44,402 (291)

Combined intranasal treatment for allergic rhinitis: an option for children under 12 years of age [PDF]

open access: yesExploration of Asthma & Allergy
Intranasal treatments combining corticosteroids with antihistamines are a safe and effective alternative for treating moderate to severe seasonal allergic rhinitis in children over 12 years of age and adults.
Alberto Vidal, Pedro Cortez
doaj   +1 more source

Chronic inducible urticaria: treatment algorithm

open access: yesЛечащий Врач, 2021
Chronic inducible urticaria (CindU) is a prevalent skin disease characterized by the appearance of recurrent wheals, angioedema or both, as a response to specific and reproducible triggers.
D. M. Skander   +2 more
doaj  

Allergic rhinitis and comorbid diseases. Otorhinolaryngologist’s view. Case report

open access: yesConsilium Medicum, 2022
Comorbid diseases aggravate allergic rhinitis (AR), require additional examination and correction of treatment. The article presents a review of publications on the relationship of AR with adenoid and exudative otitis media (EOM).
Viktoria V. Shilenkova
doaj   +1 more source

Ambient Hydrocarbonylation of Olefins Enabled by Visible‐Light

open access: yesAdvanced Science, EarlyView.
A novel photo‐induced methodology for hydrocarbonylation has been established, resolving the inherent conflicts between competitive olefin and CO insertion in traditional methods that necessitate harsh conditions. Accordingly, an efficient and versatile hydrocarbonylation of olefins enabled by visible‐light irradiation under ambient conditions has been
Hongchi Liu, Tianze Zhang, Hanmin Huang
wiley   +1 more source

Assessment of Initial Stay Time and Work‐Rest Scheduling Over Consecutive Moderate‐Intensity Workdays in Hot Environments in Young and Older Males and Females

open access: yesAmerican Journal of Industrial Medicine, EarlyView.
ABSTRACT Introduction Initial stay time (IST), the duration of continuous work before core temperature reaches 38.0°C, has been characterized in young and older adults but not across consecutive work periods or in conjunction with standard work‐rest cycles.
Glen P. Kenny   +9 more
wiley   +1 more source

The allergic scholar

open access: yesSouth African Family Practice, 2015
Allergic diseases are on the increase globally. There has been a doubling in the number of scholars suffering from allergy-related disease in the past two decades. This article describes the predisposing factors which contribute to an increased incidence
Natalie Schellack   +2 more
doaj   +1 more source

Local Specific IgE Levels Can Predict and Monitor the Therapeutic Response to Subcutaneous Immunotherapy With House Dust Mite

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Identifying predictive and monitoring biomarkers for allergen immunotherapy response is crucial for enhancing clinical efficacy. This study aims to investigate the systemic and local levels of immunoglobulins and identify potential biomarkers in house dust mite (HDM) allergic rhinitis (AR) patients who are undergoing subcutaneous ...
Xu Xu   +6 more
wiley   +1 more source

Effectiveness and safety of combination treatment of herbal medicines and oral antihistamines for atopic dermatitis: a retrospective chart review

open access: yesIntegrative Medicine Research, 2017
Background: Patients with atopic dermatitis (AD) exhibit various symptoms, especially itching. Recently, herbal medicines (HMs) are being used in combination with antihistamines for the treatment of AD in Korea.
Younghee Yun   +5 more
doaj   +1 more source

Use of antitussive medications in acute cough in young children

open access: yesJournal of the American College of Emergency Physicians Open, 2021
Acute cough, a common complaint in young children, is often the result of a viral upper respiratory infection. Cough and cold remedies generate billions of dollars in annual sales in the United States, despite a lack of evidence of their efficacy and ...
Samuel H. F. Lam   +9 more
doaj   +1 more source

Dosing Interval Extension of Dupilumab in CRSwNP: Five‐Year Real World Outcomes

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Chronic rhinosinusitis with nasal polyps (CRSwNP) is a persistent, often Type 2‐mediated inflammatory disease that markedly impairs quality of life. While dupilumab provides rapid improvement, there is limited evidence on long‐term outcomes beyond 2 years, and the clinical impact of dosing‐interval extension remains unclear.
Nicholas J. Campion   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy